Skip to main content

Advertisement

SpringerLink
Log in

Microhematuria in Women Presenting for Overactive Bladder

  • Lower Urinary Tract Symptoms and Voiding Dysfunction (J Sandhu, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Microscopic hematuria and overactive bladder are two common urologic conditions. The objective of this review is to provide an overview of current literature as well as highlight important guidelines that will aid physicians in the diagnostic workup of microscopic hematuria in patients experiencing symptoms of overactive bladder.

Recent Findings

Updated microscopic hematuria guidelines provide a structured and appropriate workup for women based on risk factors, which stratifies patients to prevent unnecessary procedures and imaging. Women presenting with microscopic hematuria in the setting of overactive bladder should undergo microscopic hematuria workup according to their risk stratification while receiving appropriate treatment for their overactive bladder.

Summary

The physician should consider the presence of irritative voiding symptoms during the investigation and management of microscopic hematuria in patients with overactive bladder and should not delay overactive bladder treatment due to the presence of microscopic hematuria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

MH:

Microscopic hematuria

LUTS:

Lower urinary tract symptoms

OAB:

Overactive bladder

AUA:

American Urologic Association

AUGS:

American Urogynecologic Society

EAU:

European Association of urology

IUGA:

International Urogynecological Association

ICS:

International Continence Society

IC/BPS:

Interstitial cystitis/bladder pain syndrome

GSM:

Genitourinary syndrome of menopause

UA:

Urinalysis

CTU:

Computerized tomography urogram

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Avellino GJ, Bose S, Wang DS. Diagnosis and management of hematuria. Surg Clin North Am. 2016;96(3):503–15. https://doi.org/10.1016/j.suc.2016.02.007.

    Article  Google Scholar 

  2. •• Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU guideline. J Urol. 2020;204(4):778–86. https://doi.org/10.1097/JU.0000000000001297. This AUA/SUFU guideline provides an evidence-based framework for providers to risk stratify and appropriately work up patients presenting with microscopic hematuria.

    Article  Google Scholar 

  3. Wein AJ. Diagnosis and treatment of the overactive bladder. Urology. 2003;62(5 Suppl 2):20–7. https://doi.org/10.1016/j.urology.2003.09.008.

    Article  Google Scholar 

  4. Arnold MJ. Microscopic hematuria in adults: updated recommendations from the American Urological Association. Am Fam Physician. 2021;104(6):655–7.

    Google Scholar 

  5. Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6S):2473–81. https://doi.org/10.1016/j.juro.2012.09.078.

    Article  Google Scholar 

  6. Tan WS, Feber A, Sarpong R, et al. Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients. Eur Urol. 2018;74(1):10–4. https://doi.org/10.1016/j.eururo.2018.03.008.

    Article  Google Scholar 

  7. Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013;88(2):129–38. https://doi.org/10.1016/j.mayocp.2012.10.004.

    Article  Google Scholar 

  8. Marks P, Soave A, Shariat SF, Fajkovic H, Fisch M, Rink M. Female with bladder cancer: what and why is there a difference? Transl Androl Urol. 2016;5(5):668–82. https://doi.org/10.21037/tau.2016.03.22.

    Article  Google Scholar 

  9. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000;163(2):524–7.

    Article  CAS  Google Scholar 

  10. Rabinowitz DE, Buford K, Wood AM, et al. Incidence of significant findings of microhematuria workup in women-what guidelines work best? Urology. 2021;151:19–23. https://doi.org/10.1016/j.urology.2020.06.046.

    Article  Google Scholar 

  11. Richter LA, Lippmann QK, Jallad K, et al. Risk factors for microscopic hematuria in women. Female Pelvic Med Reconstr Surg. 2016;22(6):486–90. https://doi.org/10.1097/SPV.0000000000000321.

    Article  Google Scholar 

  12. Matulewicz RS, Rademaker A, Meeks JJ. A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria. Urol Oncol. 2020;38(4):240–6. https://doi.org/10.1016/j.urolonc.2019.12.010.

    Article  Google Scholar 

  13. Gold SA, Kenigsberg AP, Lotan Y. Diagnostic and cost implications of the 2020 AUA microhematuria guidelines: modeling impact in a large public health care system. J Urol. 2022;207(1):52–60. https://doi.org/10.1097/JU.0000000000002175.

    Article  Google Scholar 

  14. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. https://doi.org/10.1002/nau.20798.

    Article  Google Scholar 

  15. •• Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019;202(3):558–63. https://doi.org/10.1097/JU.0000000000000309. This AUA guideline provides an evidence based approach to patients presenting with non-neurogenic overactive bladder.

    Article  Google Scholar 

  16. •• Nambiar AK, Arlandis S, Bø K, et al. European Association of Urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol. 2022;82(1):49–59. https://doi.org/10.1016/j.eururo.2022.01.045. This EAU guideline provides an evidence based approach to patients presenting with lower urinary tract symptoms including OAB and mixed urinary incontinence.

  17. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36. https://doi.org/10.1007/s00345-002-0301-4.

    Article  CAS  Google Scholar 

  18. Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71–6. https://doi.org/10.2147/RRU.S102441.

    Article  Google Scholar 

  19. Santander J, Plata M, Zuluaga L, et al. What is the real burden of the overactive bladder? Results from a national prevalence study. Neurourol Urodyn. 2022;41(4):926–34. https://doi.org/10.1002/nau.24894.

    Article  Google Scholar 

  20. Pratt TS, Suskind AM. Management of overactive bladder in older women. Curr Urol Rep. 2018;19(11):92. https://doi.org/10.1007/s11934-018-0845-5.

    Article  Google Scholar 

  21. Mckellar K, Bellin E, Schoenbaum E, Abraham N. Prevalence, risk factors, and treatment for overactive bladder in a racially diverse population. Urology. 2019;126:70–5. https://doi.org/10.1016/j.urology.2018.12.021.

    Article  Google Scholar 

  22. Ikeda Y, Nakagawa H, Ohmori-Matsuda K, et al. Risk factors for overactive bladder in the elderly population: a community-based study with face-to-face interview. Int J Urol. 2011;18(3):212–8. https://doi.org/10.1111/j.1442-2042.2010.02696.x.

    Article  Google Scholar 

  23. Zhu J, Hu X, Dong X, Li L. Associations between risk factors and overactive bladder: a meta-analysis. Female Pelvic Med Reconstr Surg. 2019;25(3):238–46. https://doi.org/10.1097/SPV.0000000000000531.

    Article  Google Scholar 

  24. de Boer TA, Slieker-ten Hove MCP, Burger CW, Vierhout ME. The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population. Int Urogynecol J. 2011;22(5):569–75. https://doi.org/10.1007/s00192-010-1323-x.

    Article  Google Scholar 

  25. Leron E, Weintraub AY, Mastrolia SA, Schwarzman P. Overactive bladder syndrome: evaluation and management. Curr Urol. 2018;11(3):117–25. https://doi.org/10.1159/000447205.

    Article  Google Scholar 

  26. de Groat WC. A neurologic basis for the overactive bladder. Urology. 1997;50(6A Suppl):36–52. https://doi.org/10.1016/s0090-4295(97)00587-6.

    Article  Google Scholar 

  27. Brading A. Spontaneous activity of lower urinary tract smooth muscles: correlation between ion channels and tissue function. J Physiol. 2006;570(Pt 1):13–22. https://doi.org/10.1113/jphysiol.2005.097311.

    Article  CAS  Google Scholar 

  28. Drake MJ, Mills IW, Gillespie JI. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet. 2001;358(9279):401–3. https://doi.org/10.1016/s0140-6736(01)05549-0.

    Article  CAS  Google Scholar 

  29. Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn. 2010;29(1):97–106. https://doi.org/10.1002/nau.20784.

    Article  Google Scholar 

  30. Raju R, Linder BJ. Evaluation and treatment of overactive bladder in women. Mayo Clin Proc. 2020;95(2):370–7. https://doi.org/10.1016/j.mayocp.2019.11.024.

    Article  Google Scholar 

  31. Kirby AC, Park S, Cook SB, Odem-Davis K, Gore JL, Wolff EM. Practice patterns for women with overactive bladder syndrome: time between medications and third-line treatments. Female Pelvic Med Reconstr Surg. 2020;26(7):431–6. https://doi.org/10.1097/SPV.0000000000000811.

    Article  Google Scholar 

  32. Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020;12(4):e7586. https://doi.org/10.7759/cureus.7586.

    Article  Google Scholar 

  33. Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–11. https://doi.org/10.1016/j.ajog.2016.07.045.

    Article  Google Scholar 

  34. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. Br Med J. 1980;281(6250):1243–5. https://doi.org/10.1136/bmj.281.6250.1243.

    Article  CAS  Google Scholar 

  35. Haspels AA, Luisi M, Kicovic PM. Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol. Maturitas. 1981;3(3–4):321–7. https://doi.org/10.1016/0378-5122(81)90041-4.

    Article  CAS  Google Scholar 

  36. Manson JE, Chlebowski RT, Stefanick ML, et al. The Women’s Health Initiative hormone therapy trials: update and overview of health outcomes during the intervention and post-stopping phases. JAMA. 2013;310(13):1353–68. https://doi.org/10.1001/jama.2013.278040.

    Article  CAS  Google Scholar 

  37. Bhupathiraju SN, Grodstein F, Stampfer MJ, et al. Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study. Menopause. 2018;26(6):603–10. https://doi.org/10.1097/GME.0000000000001284.

    Article  Google Scholar 

  38. Rahn DD, Carberry C, Sanses TV, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol. 2014;124(6):1147–56. https://doi.org/10.1097/AOG.0000000000000526.

    Article  CAS  Google Scholar 

  39. Beerepoot MAJ, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190(6):1981–9. https://doi.org/10.1016/j.juro.2013.04.142.

    Article  CAS  Google Scholar 

  40. Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10:CD001405. https://doi.org/10.1002/14651858.CD001405.pub3.

    Article  Google Scholar 

  41. Ellington DR, Szychowski JM, Malek JM, Gerten KA, Burgio KL, Richter HE. Combined tolterodine and vaginal estradiol cream for overactive bladder symptoms after randomized single-therapy treatment. Female Pelvic Med Reconstr Surg. 2016;22(4):254–60. https://doi.org/10.1097/SPV.0000000000000256.

    Article  Google Scholar 

  42. Gomes CM, Sánchez-Ortiz RF, Harris C, Wein AJ, Rovner ES. Significance of hematuria in patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology. 2001;57(2):262–5. https://doi.org/10.1016/S0090-4295(00)00918-3.

    Article  CAS  Google Scholar 

  43. • Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208(1):34–42. https://doi.org/10.1097/JU.0000000000002756. Patients with IC/BPS can present with MH and this outlines the approach to workup and management of these patients.

    Article  Google Scholar 

  44. • Ferrante KL, Wasenda EJ, Jung CE, Adams-Piper ER, Lukacz ES. Vaginal estrogen for the prevention of recurrent urinary tract infection in postmenopausal women: a randomized clinical trial. Female Pelvic Med Reconstr Surg. 2021;27(2):112–7. https://doi.org/10.1097/SPV.0000000000000749. Topical vaginal estrogen is a therapeutic option for patients presenting with GSM as well as recurrent UTIs, both of which can lead to microscopic hematuria in female patients.

    Article  Google Scholar 

  45. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;2:CD005131. https://doi.org/10.1002/14651858.CD005131.pub2.

    Article  Google Scholar 

  46. Samson P, Waingankar N, Shah P, Friedman D, Kavoussi L, Han J. Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria. Urol Oncol. 2018;36(1):10.e1-10.e6. https://doi.org/10.1016/j.urolonc.2017.09.011.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Maimonides Medical Center, Brooklyn, NY, USA

    Karis Buford, Dhaval Jivanji & Allison Polland

Authors
  1. Karis Buford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dhaval Jivanji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allison Polland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karis Buford.

Ethics declarations

Conflict of Interest

The authors do not have existing conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Lower Urinary Tract Symptoms and Voiding Dysfunction

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buford, K., Jivanji, D. & Polland, A. Microhematuria in Women Presenting for Overactive Bladder. Curr Urol Rep 24, 25–32 (2023). https://doi.org/10.1007/s11934-022-01128-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-022-01128-3

Keywords

Search

Navigation